Washington, DC 20006-5349
HELPLINE
MESOTHELIOMA NEWS
Scroll to find news of interest to you, or search by category. The Mesothelioma Applied Research Foundation covers mesothelioma news for patients and their families. Our write-ups are heavily reliant on peer-reviewed medical research studies with input from mesothelioma experts from around the world but are also accessible to non-medical readers.
Since 2008, the Department of Defense has funded mesothelioma research through its Congressionally Directed Medical Research Program – more specifically, through the Peer Reviewed Cancer
The challenges of treating mesothelioma are well known to this community of patients, caregivers, bereaved, and the physicians who treat them. Particularly, researchers have been
The Mesothelioma Applied Research Foundation is pleased to announce the addition of seven new members to its science advisory board (SAB). Madhavi Ganapathiraju, PhD – University of Pittsburgh Jonathan
A Phase 3 trial in relapsed mesothelioma patients showed a significant improvement in overall survival and progression-free survival when patients were treated with nivolumab. Nivolumab
The Mesothelioma Applied Research Foundation is pleased to announce the addition of five new members to the organization’s board of directors. Jessica Blackford-Cleeton – Springfield, Illinois Cheryl Bruner, Esq. – Louisville, Kentucky Randy Krocka – Sheet
This MesoTV panel of four mesothelioma patients and one caregiver discuss survivors’ guilt and other issues affecting mesothelioma survivors. Chris DeSantis Heather Von St James
Today, the Mesothelioma Applied Research Foundation, among 130 organizations, cancer centers, and other institutions, sent a letter to President Joseph R. Biden, key members of
The Congressionally Directed Medical Research Programs’ (CDMPR), Rare Cancers Research Program (RCRP) consumer advocate Jessica Blackford-Cleeton recently participated in the evaluation of research applications submitted